NO164353C - Analogifremgangsmaate til fremstilling av terapeutisk aktive pyridopyrimidiner. - Google Patents

Analogifremgangsmaate til fremstilling av terapeutisk aktive pyridopyrimidiner.

Info

Publication number
NO164353C
NO164353C NO855342A NO855342A NO164353C NO 164353 C NO164353 C NO 164353C NO 855342 A NO855342 A NO 855342A NO 855342 A NO855342 A NO 855342A NO 164353 C NO164353 C NO 164353C
Authority
NO
Norway
Prior art keywords
pyridopyrimidines
preparation
therapeutic active
analogy procedure
analogy
Prior art date
Application number
NO855342A
Other languages
English (en)
Other versions
NO164353B (no
NO855342L (no
Inventor
Horst Meyer
Egbert Wehinger
Bernward Garthoff
Stanislav Kazda
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO855342L publication Critical patent/NO855342L/no
Publication of NO164353B publication Critical patent/NO164353B/no
Publication of NO164353C publication Critical patent/NO164353C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
NO855342A 1985-01-19 1985-12-30 Analogifremgangsmaate til fremstilling av terapeutisk aktive pyridopyrimidiner. NO164353C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19853501696 DE3501696A1 (de) 1985-01-19 1985-01-19 Pyridopyrimidine, mehrere verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Publications (3)

Publication Number Publication Date
NO855342L NO855342L (no) 1986-07-21
NO164353B NO164353B (no) 1990-06-18
NO164353C true NO164353C (no) 1990-09-26

Family

ID=6260235

Family Applications (1)

Application Number Title Priority Date Filing Date
NO855342A NO164353C (no) 1985-01-19 1985-12-30 Analogifremgangsmaate til fremstilling av terapeutisk aktive pyridopyrimidiner.

Country Status (18)

Country Link
US (1) US4621082A (no)
EP (1) EP0189045B1 (no)
JP (1) JPS61167688A (no)
CN (1) CN1010947B (no)
AT (1) ATE50407T1 (no)
AU (1) AU578783B2 (no)
CA (1) CA1276636C (no)
DE (2) DE3501696A1 (no)
DK (1) DK23386A (no)
ES (1) ES8704491A1 (no)
FI (1) FI81574C (no)
GR (1) GR860117B (no)
HU (1) HU195812B (no)
NO (1) NO164353C (no)
NZ (1) NZ214842A (no)
PH (1) PH22610A (no)
PT (1) PT81860B (no)
ZA (1) ZA86363B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU598093B2 (en) * 1987-02-07 1990-06-14 Wellcome Foundation Limited, The Pyridopyrimidines, methods for their preparation and pharmaceutical formulations thereof
CA2074933C (en) * 1990-11-30 2002-12-03 Masatoshi Chihiro Thiazole derivatives as active superoxide radical inhibitors
JPH04260503A (ja) * 1991-02-13 1992-09-16 Sekisui Jushi Co Ltd ピッキングシステム
JP3013905B2 (ja) * 1991-06-28 2000-02-28 花王株式会社 自動倉庫の入出庫方法
PT100905A (pt) * 1991-09-30 1994-02-28 Eisai Co Ltd Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem
US5405848A (en) * 1993-12-22 1995-04-11 Ortho Pharmaceutical Corporation Substituted thiazolylaminotetrahydropyridopyrimidines derivatives useful as platelet aggregation inhibitors
US6756367B2 (en) 1998-02-03 2004-06-29 Novartis Ag Benzo-oxadiazoles, -thiadiazoles and -1,4-diazines, pharmaceutical compositions containing them and a process for preparing them
US6184226B1 (en) 1998-08-28 2001-02-06 Scios Inc. Quinazoline derivatives as inhibitors of P-38 α
JP2006515846A (ja) * 2002-12-13 2006-06-08 ニューロジェン・コーポレーション カプサイシン受容体モジュレーターとしての2−置換キナゾリン−4−イルアミン類似体
US20070082920A1 (en) * 2005-10-06 2007-04-12 Yongsheng Song NAD+-dependent DNA ligase inhibitors
DE102006026583A1 (de) * 2006-06-07 2007-12-13 Bayer Healthcare Aktiengesellschaft Aryl-substituierte hetero-bicyclische Verbindungen und ihre Verwendung
DE102006026585A1 (de) * 2006-06-07 2007-12-13 Bayer Healthcare Aktiengesellschaft Substituierte 4-Aryl-1,4-dihydro-1,6-naphthyridine und ihre Verwendung
WO2017133542A1 (zh) * 2016-02-04 2017-08-10 江苏恒瑞医药股份有限公司 一种含有吡啶并嘧啶类衍生物或其可药用盐的药物组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3021332A (en) * 1954-01-04 1962-02-13 Burroughs Wellcome Co Pyrido (2, 3-d) pyrimidine compounds and method of making
GB1129084A (en) * 1965-02-18 1968-10-02 Wellcome Found Novel pyrido[2,3-d]pyrimidines
DE3438350A1 (de) * 1984-10-19 1986-04-24 Gödecke AG, 1000 Berlin 4-oxo-pyrido (2,3-d) pyrimidin-derivate, verfahren zu deren herstellung und deren verwendung
DE3438351A1 (de) * 1984-10-19 1986-04-24 Gödecke AG, 1000 Berlin 4-alkoxy-pyrido(2,3-d)pyrimidin-derivate, verfahren zu deren herstellung und deren verwendung

Also Published As

Publication number Publication date
DE3669041D1 (de) 1990-03-22
FI81574B (fi) 1990-07-31
ES551013A0 (es) 1987-04-01
NZ214842A (en) 1988-07-28
PH22610A (en) 1988-10-17
NO164353B (no) 1990-06-18
FI860197A (fi) 1986-07-20
AU5219386A (en) 1986-07-24
EP0189045A2 (de) 1986-07-30
PT81860A (en) 1986-02-01
US4621082A (en) 1986-11-04
CN86100279A (zh) 1986-11-19
FI860197A0 (fi) 1986-01-16
NO855342L (no) 1986-07-21
ES8704491A1 (es) 1987-04-01
PT81860B (pt) 1988-05-27
ATE50407T1 (de) 1990-02-15
HUT40127A (en) 1986-11-28
CA1276636C (en) 1990-11-20
GR860117B (en) 1986-05-16
ZA86363B (en) 1986-09-24
AU578783B2 (en) 1988-11-03
DK23386A (da) 1986-07-20
CN1010947B (zh) 1990-12-26
HU195812B (en) 1988-07-28
DE3501696A1 (de) 1986-07-24
FI81574C (fi) 1990-11-12
DK23386D0 (da) 1986-01-17
JPS61167688A (ja) 1986-07-29
EP0189045B1 (de) 1990-02-14
EP0189045A3 (en) 1988-10-05

Similar Documents

Publication Publication Date Title
NO165344C (no) Analogifremgangsmaate for fremstilling av teraputisk aktive indolizin-derivater.
NO167142C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive heterocykliske derivater.
NO167384C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-aralkylpiperidinmethanolderivater.
NO163406C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinolinonderivater.
NO168770C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
NO862477D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-arylimidazol-derivater.
NO170629C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater
NO862650D0 (no) Fremgangsmaate for fremstilling av heterocykliske substituert-fenoksyalkyl isoksazoler og -furaner.
NO871588D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske karboksamider.
NO164353C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive pyridopyrimidiner.
NO164169C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzothiazinderivater.
NO168299C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater
ES2017764B3 (es) Procedimiento para el tratamiento de celulas primarias utilizadas
NO169069C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-alkoksy-2-aminopropylaminderivater
NO164895C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dikloranilinderivater.
NO168103C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aralkylimidazolderivater
NO821083L (no) Fremgangsmaate for fremstilling av terapeutisk aktive morfantridin-derivater
ATE17945T1 (de) 7-phenyl-7-phenoxymethyl-hexahydro-1,4-oxazepin , ihre herstellung und verwendung.
NO166715C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cytorodin s derivater.
NO872825D0 (no) Fremgangsmaate for fremstilling av antibakterielt aktive cefalosporinderivater.
DK204780A (da) 3-substituerede hexahydropyrimido (1,2-a) azepiner eller salte deraf deres fremstilling og anvendelse
NO870499L (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser.
NO164028C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive allopurinol-derivater.
NO921475D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive catecholderivater
NO165724C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive arylcyklobutylkylaminer.